<p>Bharat Biotech has sought permission from Drugs Controller General of India (DCGI) to conduct a phase 2/3 study of its anti-COVID vaccine Covaxin as a booster dose among those aged two to 17 years, sources told PTI.</p>
<p>Presently, precaution dose of Covaxin and Covishield is administered to all those aged 18 and above, and have completed nine months after the second dose.</p>
<p>The Hyderabad-based company submitted the application for the trial to the DCGI on April 29. The study is likely to be conducted in six sites, including Delhi (at AIIMS) and Patna.</p>
<h2>Kerala reports 29 deaths in 24 hours, nationwide tally is 31&nbsp;</h2>
<p>India reported 3,205 fresh novel Coronavirus infections in a day, pushing the number of active cases to 19,509 and the overall tally to 4,30,88,118, according to the Union Health Ministry data updated Wednesday.&nbsp;</p>
<p>The data released at 8 am also showed that 31 fatalities from COVID&mdash;29 of them from Kerala alone&mdash;were reported in a 24-hour span, taking the cumulative death toll to 5,23,920. An increase of 372 cases has been recorded in the active COVID-19 caseload which now stand at 19,509.</p>
<p><strong>4,30,88,118</strong> Total no. of Coronavirus cases in india so far<br /><strong>5,23,920</strong> Total no. of deaths due to the virus in India so far<br /><strong>19,509</strong> Total no. of active cases in India</p>
<p><span style="font-size: x-small;"><em>This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever</em></span></p><p>
    <script async="async" data-cfasync="false" src="//pl23789885.revenuecpmgate.com/7445444aea29efc3d061cbd866026c06/invoke.js"></script>
    <div id="container-7445444aea29efc3d061cbd866026c06"></div>
    </p>

Seeks nod from DCGI for phase 2/3 trial of Covaxin, among 2-to-17 age group

Bharat Biotech seeks booster trial on kids

Trending Stories

Latest Photos

Latest Videos

Latest Web Stories

Mid-Day Fast

Home / News / India News / Article / Bharat Biotech seeks booster trial on kids

Bharat Biotech seeks booster trial on kids

Trending Stories

Latest Photos

Latest Videos

Latest Web Stories

Mid-Day Fast